Zinc-doped bioactive glass composite hydrogel, preparation method thereof and application of zinc-doped bioactive glass composite hydrogel in preparation of wound repair material

Through the combination of acylhydrazone bond crosslinking reaction and buffer solution of zinc-doped bioactive glass composite hydrogel, the problem of existing wound repair materials being difficult to achieve hemostasis, antibacterial and promote skin attachment regeneration is achieved, and rapid healing and functional repair are achieved , avoiding the use of toxic activators.

CN119055844APending Publication Date: 2024-12-03SHANGHAI INST OF CERAMIC CHEM & TECH CHINESE ACAD OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310633706.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-31
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing trauma repair materials are difficult to achieve rapid hemostasis, antibacterial and promote skin attachment regeneration at the same time, and the activators used during the preparation process are toxic and cannot effectively repair skin functions.

Method used

Using zinc-doped bioactive glass composite hydrogel, the gel is quickly formed through acyl hydrazone bond cross-linking reaction, combined with buffer solution to form a matrix, containing aldehyde groups and hydrazide polymers and zinc-doped bioactive glass powder, quickly sealing the wound surface and releasing it Bioactive silicon and zinc ions promote wound healing and skin attachment regeneration.

Benefits of technology

It achieves rapid hemostasis, antibacterial, promotes wound healing and regeneration of skin attachments, avoids the use of toxic activators, and improves the effect of trauma repair.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119055844A_ABST
    Figure CN119055844A_ABST
Patent Text Reader

Abstract

The invention relates to zinc-doped bioactive glass composite hydrogel, a preparation method thereof and application of the zinc-doped bioactive glass composite hydrogel in preparation of wound repair materials. The zinc-doped bioactive glass composite hydrogel comprises hydrogel as a matrix and zinc-doped bioactive glass powder dispersed in the matrix, wherein the hydrogel is formed by an aldehyde group-containing polymer, a hydrazide-containing polymer and a buffer solution; preferably, the content of the zinc-doped bioactive glass powder is 0.5 to 2.0 wt%.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a zinc-doped bioactive glass composite medical hydrogel based on acylhydrazone bonds, and also relates to a preparation method and application of the composite hydrogel material, belonging to the fields of biomedicine, material technology, wound repair and medical equipment. Background Art

[0002] The skin is the largest organ in the human body and plays a barrier and protective role. The skin structure is complex. However, due to its location on the body surface, skin trauma caused by various accidents and medical operations is a common clinical phenomenon. There are approximately 300 million patients with acute skin injuries worldwide each year, and tens of millions of skin traumas caused by various accidents in my country each year. It is of great significance to reduce the secondary damage caused by sutures, prevent bleeding and tissue fluid leakage from surgical wounds, avoid wound infection that leads to delayed healing or even non-healing, and promote rapid recovery of wounds. Therefore, the development of an ideal wound repair medical dressing that can be both hemostatic and antibacterial is very necessary to better meet the clinical effective treatment.

[0003] The restoration of skin function is crucial during wound repair. Skin damage can lead to the complete destruction of skin appendages (hair follicles, sweat glands, and sebaceous glands). During the re-epithelialization process of adult wounds, the signals that induce hair and sweat gland regeneration cannot be received. Therefore, hair follicles and sweat glands cannot be regenerated during wound tissue healing, and only scar repair can be achieved, which brings serious psychological burden and physiological disorders to patients. At present, research on skin appendage repair is still very limited. Most wound dressings focus on improving the healing speed of wounds, and rarely consider promoting the regeneration of skin appendages and repairing skin function.

[0004] Silicon ions released by silicon-based bioactive ceramics during degradation can promote cell proliferation and differentiation and strengthen cell-to-cell interactions, thereby promoting angiogenesis, epithelialization and collagen deposition at the site of injury, and ultimately promoting the entire wound repair process. Bioactive silicon ions and zinc ions can stimulate the proliferation and migration of endothelial cells and fibroblasts, promote rapid healing of skin wounds, and zinc ions can promote the regeneration of hair follicles.

[0005] Chinese invention patent CN201910143983.7 discloses a porous hemostatic sponge prepared by rapid cross-linking to form a gel and freeze-drying with polyglutamic acid and polylysine as the matrix, casein as the foaming agent, and calcium ions. It can be antibacterial and promote healing, and can quickly and effectively stop bleeding. It relies on high porosity to achieve a hemostatic effect, but it cannot seal the wound and continuously provide a moist environment. In addition, the activators 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) used in the preparation process have certain toxicity and cannot be removed. Although it can promote wound repair, it cannot promote the regeneration and repair of the skin appendages in the wound area. Summary of the invention

[0006] To this end, the present invention provides a zinc-doped bioactive glass composite hydrogel and a preparation method thereof and application of the composite hydrogel in preparing wound repair materials.

[0007] On the one hand, the present invention provides a zinc-doped bioactive glass composite hydrogel, comprising: a polymer containing an aldehyde group, a polymer containing a hydrazide and a buffer solution to form a hydrogel as a matrix, and zinc-doped bioactive glass powder dispersed in the matrix; preferably, the content of the zinc-doped bioactive glass powder is 0.5-2.0wt%.

[0008] Preferably, the particle size of the zinc-doped bioactive glass powder is less than 100 microns.

[0009] Preferably, the mass ratio of the polymer containing aldehyde group, the polymer containing hydrazide and the zinc-doped bioactive glass is (1% to 20%): (1% to 20%): (0.5 to 2.0%)

[0010] Preferably, the components of the zinc-doped bioactive glass powder contain inorganic oxides of ZnO, CaO, SiO2 and P2O5; preferably, the components of the zinc-doped bioactive glass powder, based on 100wt% by mass, have a Zn content of 10% to 30%, a P2O5 content of 3 to 20%, a SiO2 content of 40 to 80%, and a CaO content of 10% to 60%;

[0011] Preferably, the zinc-doped bioactive glass is doped with at least one of potassium, lithium, magnesium, boron, copper and strontium; the doping content is 1-20%.

[0012] Preferably, the buffer solution comprises at least one of disodium hydrogen phosphate-sodium dihydrogen phosphate buffer solution, morpholineethanesulfonic acid buffer solution, disodium hydrogen phosphate-citric acid buffer solution and citric acid-sodium citrate buffer solution, with a pH of 5 to 7; The sum of the mass of the polymer containing aldehyde groups and the polymer containing hydrazide is 1-20wt% of the total mass of the polymer containing aldehyde groups, the polymer containing hydrazide and the buffer solution.

[0013] Preferably, the mass ratio of the aldehyde-containing polymer to the zinc-doped bioactive glass powder is (1-20): (0.5-2.0); The polymer containing aldehyde groups includes sodium alginate oxidized by periodic acid, dextran oxidized by periodic acid, hyaluronic acid oxidized by periodic acid, and aldehyde-modified polyglutamic acid.

[0014] Preferably, the mass ratio of the hydrazide-containing polymer to the zinc-doped bioactive glass powder is (1-20): (0.5-2.0); The hydrazide-containing polymer includes adipic acid dihydrazide-modified polyglutamic acid.

[0015] On the other hand, the present invention provides a method for preparing a zinc-doped bioactive glass composite hydrogel, comprising: mixing a buffer solution of a polymer containing an aldehyde group and a buffer solution of a polymer containing an amino group, and then adding zinc-doped bioactive glass powder to mix into a gel to obtain the zinc-doped bioactive glass composite hydrogel.

[0016] In yet another aspect, the present invention provides a use of a zinc-doped bioactive glass composite hydrogel in preparing a wound repair material.

[0017] Beneficial effects: In the present invention, the cross-linking reaction type of the polymer containing aldehyde groups (such as oxidized alginate, etc.) and the polymer containing hydrazide (such as adipic acid dihydrazide modified polyglutamic acid, etc.) is acylhydrazone bond, and the formation of acylhydrazone bond will be affected by the pH value of the system. Under weakly acidic conditions, the cross-linking reaction proceeds rapidly and gelation is rapid. Zinc-doped bioactive glass will reduce the pH value of the bioactive glass without significantly changing the formation rate of acylhydrazone bonds, so that the zinc-doped bioactive glass composite hydrogel can quickly gel, quickly seal the wound surface, keep the wound surface moist, and achieve the purpose of hemostasis and antibacterial; at the same time, the zinc-doped bioactive glass slowly and continuously releases bioactive silicon ions and zinc ions in the damaged skin area, promoting angiogenesis and hair follicle regeneration at the wound site, thereby achieving the goal of promoting rapid healing of the wound surface and repairing the function of skin appendages. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 A is the picture of zinc-doped bioactive glass powder, B is the XRD picture of zinc-doped bioactive glass powder, C is the pH value of zinc-doped bioactive glass powder, D is the antibacterial rate of zinc-doped bioactive glass, and E is the picture of bacterial colonies after bacterial plating; Figure 2A is the gelation time of hydrogels with different 30Zn58S addition amounts, B is the pH change of MES buffer after adding different amounts of 30Zn58S, and C is the device for using 1% ZnBG / OSA. The oxidized sodium alginate solution mixed with 1% ZnBG and the adipic acid dihydrazide modified γ-polyglutamic acid solution are placed in two tubes respectively. When extruded, they can be mixed evenly to form gel quickly, and have good injectability. Figure 3 A is the bonding strength of hydrogels with different 30Zn58S addition amounts to pig skin, B is the ability of 1% ZnBG / OSA hydrogel to firmly bond to pig skin, C is the bursting pressure of 1% ZnBG / OSA on pig small intestine, and D is a diagram of the bursting pressure test device Figure 4 A is the coagulation time test, and B is the photo of the coagulation time test; Figure 5 The results of the antibacterial experiment; Figure 6 Ion release rate of 1% ZnBG / OSA composite hydrogel. DETAILED DESCRIPTION

[0019] The present invention is further described below by the following embodiments. It should be understood that the following embodiments are only used to illustrate the present invention, but not to limit the present invention.

[0020] In the present disclosure, the zinc-doped bioactive glass composite hydrogel is obtained by mixing at least a polymer containing an aldehyde group, a polymer containing a hydrazide, a zinc-doped bioactive glass powder, and a buffer solution with a pH range of 5.0 to 7.0. The mass ratio of the polymer containing an aldehyde group, the polymer containing an amino group, and the silicon-based bioactive glass powder can be (1% to 20%): (1% to 20%): (0.5 to 2.0%).

[0021] The following is an exemplary description of the preparation method of zinc-doped bioactive glass composite hydrogel.

[0022] The polymer containing aldehyde groups is dissolved in a buffer solution with a pH range of 5.0 to 7.0 to obtain a solution A with a mass fraction of 1% to 20% of the polymer containing aldehyde groups. The polymer containing aldehyde groups includes sodium alginate oxidized with periodic acid, dextran oxidized with periodic acid, hyaluronic acid oxidized with periodic acid, and aldehyde-modified polyglutamic acid.

[0023] The polymer containing hydrazide is dissolved in a buffer solution with a pH range of 5.0 to 7.0 to obtain a solution B with a mass volume fraction of 1% to 20% of the polymer containing hydrazide. The polymer containing hydrazide includes adipic acid dihydrazide modified polyglutamic acid.

[0024] The polymer solution containing aldehyde groups and the polymer solution containing amino groups are mixed in equal proportions, and then 0.5-2.0% of zinc-doped bioactive glass powder is added and mixed into a gel.

[0025] In an optional embodiment, the zinc-doped bioactive glass is an inorganic oxide containing ZnO, CaO, SiO2 and P2O5, or a doped inorganic oxide containing ZnO, CaO, SiO2 and P2O5. In the zinc-doped bioactive glass, the content of ZnO is 10% to 30%, the content of P2O5 is 3 to 20%, the content of SiO2 is 40 to 80%, and the content of CaO is 10% to 60% by mass. The particle size of the zinc-doped bioactive glass powder is less than 100 microns.

[0026] Preferably, the zinc-doped bioactive glass is doped with at least one of potassium, lithium, magnesium, boron, copper and strontium (these elements exist in the glass in the form of oxides), and the doping content is 1-20%. In the zinc-doped bioactive glass, by mass, the content of ZnO is 0%-30%, the content of P2O5 is 3-20%, the content of SiO2 is 40-80%, the content of CaO is 10%-60%, and the content of MO is 10%-20%. x 1~20%.

[0027] The following further examples are given to illustrate the present invention in detail. It should also be understood that the following examples are only used to further illustrate the present invention and cannot be understood as limiting the scope of protection of the present invention. Some non-essential improvements and adjustments made by those skilled in the art based on the above content of the present invention belong to the scope of protection of the present invention. The specific process parameters and the like in the following examples are also only examples within a suitable range, that is, those skilled in the art can make a selection within a suitable range through the description herein, and are not limited to the specific values ​​​​exemplified below.

[0028] Example 1 (1) Preparation of zinc-doped bioactive glass: 2 mol / L HCl solution was mixed with a certain volume of deionized water and magnetically stirred to make the mixture uniform. TEOS, triethyl phosphate, calcium nitrate tetrahydrate and zinc nitrate hexahydrate were added in sequence every 30 minutes. After all samples were added, stirring was continued for 20 minutes to obtain a uniform and transparent bioactive glass sol solution. After aging at room temperature for 3 days, the solution was placed in an oven at 60°C for 3 days and then dried at 120°C for 3 days to obtain zinc-doped bioactive glass xerogel powder. After calcination at 600°C for 3 hours, the molar ratio of CaO, P2O5, SiO2 and ZnO was set to (60-x):36:4:x, where x=0, 10, 20, and 30, respectively named BG, 10ZnBG, 20ZnBG and 30ZnBG; (2) pH determination of zinc-doped bioactive glass: prepare 0.05 mol / L tris-HCl solution (pH = 7.40), add zinc-doped bioactive glass powder at a ratio of 200 mL / g, stir evenly for 10 minutes and then test the pH value; (3) Antibacterial properties of zinc-doped bioactive glass: The frozen Staphylococcus aureus was revived and added to the bacterial culture medium and then cultured in a shaker at 37°C and 120 rpm for 12 hours; the zinc-doped bioactive glass powder was sterilized at high temperature, 200 mg of different powders were added to 1 ml of bacterial culture medium, and 0.1 ml of Staphylococcus aureus bacterial suspension with OD (optical density, 600 nm) = 0.01 was added. A blank control was set as 1 ml of bacterial culture medium with 0.1 ml of Staphylococcus aureus bacterial suspension with OD = 0.01 added. The Staphylococcus aureus bacterial suspension was cultured in a shaker at 37°C and 120 rpm for 12 hours; the cultured Staphylococcus aureus bacterial suspension was gradiently diluted 1×10 5 times, take 25 μl of the diluted bacterial solution and evenly spread it on a 10 cm agar culture plate, place the culture plate in a 37°C oven for 16 hours; collect the culture plate and take pictures. The number of colonies in the blank control group is recorded as C, and the number of colonies in the experimental group is recorded as X, then the antibacterial rate R is: R% = 100% × (CX) / C.

[0029] Example 2 (1) Preparation of oxidized sodium alginate: First, dissolve powdered sodium alginate (1.0 g, 5 mmol) in 100 mL of deionized water and stir to completely dissolve. Then, add sodium periodate (0.054 g, 0.25 mmol) in a dark environment and react for 2 hours to achieve oxidation of the sodium alginate. Finally, add an excess of ethylene glycol (1.5 ml) to terminate the reaction and obtain an oxidized sodium alginate solution. Finally, pour the obtained oxidized sodium alginate solution into a dialysis bag (molecular weight cutoff 30,000 Da) and dialyze for 3 days, changing the water twice a day. After freeze-drying, oxidized sodium alginate is obtained for later use. (2) The steps of modifying γ-polyglutamic acid with adipic acid dihydrazide are as follows: First, dissolve 1.0 g of powdered γ-polyglutamic acid in 100 ml of deionized water. After fully dissolved, add 0.57 g of adipic acid dihydrazide and 0.26 g of N-hydroxysuccinimide and stir to dissolve. Then, adjust the pH to 5.0-5.5, add 0.60 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and react for 12 hours. Finally, add the obtained adipic acid dihydrazide-modified γ-polyglutamic acid solution to a dialysis bag (molecular weight cutoff 30,000 Da) and dialyze for 3 days, changing the water twice a day. After freeze-drying, obtain adipic acid dihydrazide-modified γ-polyglutamic acid for use; (3) Prepare a morpholineethanesulfonic acid buffer solution (MES) with a pH of 5.50, prepare adipic acid dihydrazide modified γ-polyglutamic acid solution (20wt%) and oxidized sodium alginate solution (20wt%), and set aside. Take 1 ml of oxidized sodium alginate solution, add 30Zn58S (0%, 0.2%, 0.5%, 1.0%, 1.5% and 2.0% of the system mass), mix well, and then mix with adipic acid dihydrazide modified γ-polyglutamic acid solution to obtain Zn58S / OSA composite hydrogel with corresponding zinc-doped bioactive glass concentration. Use a pH meter to record the change of pH value of 30Zn58S in MES buffer solution over time.

[0030] Example 3 (1) Tissue adhesion strength test: Fresh pigskin was selected to test the adhesion strength of the hydrogel. The clean fresh pigskin was cut into thin strips of 35 mm × 10 mm. Then, 100 μl of the freshly mixed hydrogel was dripped onto a piece of pigskin and covered with another piece of pigskin of the same size to form a contact area of ​​10 mm × 10 mm. Finally, a load of 50 g was applied on it. After 4 hours, the hydrogel was stretched by a universal mechanical testing machine to measure the adhesion strength of the hydrogel to the pigskin. (2) Burst pressure test: Clean fresh pig small intestine, cut into 10 cm lengths, and remove excess fat. Use a scalpel to make a circular incision with a diameter of 5 mm, then drip 100 μl of the freshly mixed hydrogel into the circular incision, let it stand for 5 minutes, and then perform a burst pressure test. Use a digital pressure gauge to measure the burst pressure. Use a syringe to inject air at a rate of 2 mL / min to continuously increase the pressure. When the pressure value drops, it is considered that the maximum burst pressure has been reached. Measure 5 parallel samples in each group.

[0031] Example 4 In vitro coagulation test: Sodium citrate was added to fresh mouse blood as an anticoagulant. 500 μL of whole blood was taken and added with 100 μL of 0.25M calcium chloride as a control. Then 500 μL of whole blood was taken, 1 mg of 30ZnBG, 100 μL of OSA hydrogel, and 100 μL of 1% ZnBG / OSA hydrogel were added. The test tube was tilted at a frequency of once every 15 seconds until the blood in the tube stopped flowing. The blood was considered to be coagulated, and the blood coagulation time was recorded.

[0032] Example 5 Antibacterial experiment: 1 ml of hydrogel was mixed with 2 ml of 10 7CFU / mL of bacterial solution was co-cultured, and a blank control group was set up. After incubation in the cell culture incubator for 24 hours, 50 μL of the bacterial solution co-cultured with the hydrogel was taken, diluted 1000 times, and 100 μL was applied on an agar solid culture medium plate. After incubation at 37°C for 24 hours, observation and photography were performed. The number of colonies in the blank control group was recorded as C, and the number of colonies in the experimental group was recorded as X, then the antibacterial rate R is: R% = 100% × (CX) / C.

[0033] Example 6 Degradation experiment: In vitro degradation behavior of 1% ZnBG / OSA composite hydrogel was sampled at 1 day, 3 days and 7 days in a Tris-HCl solution at a ratio of 1 g / 2.5 mL in an oscillator at 37°C. The Tris-HCl solution was collected and renewed each time. The concentrations of Ca, Si and Zn ions in the collected solutions were determined by inductively coupled plasma atomic emission spectrometry (ICP-AES, VarianVista, USA). Each sample was repeated three times.

[0034] Figure 1 A is a picture of zinc-doped bioactive glass powder, B is an XRD picture of zinc-doped bioactive glass powder, C is the pH value of zinc-doped bioactive glass powder, D is the antibacterial rate of zinc-doped bioactive glass and E is a picture of the colony after bacterial plating. It can be seen from the figures that the zinc-doped bioactive glass powders are all white powders, and the XRD results show that the four powders are all in an amorphous state, indicating a glass phase. The pH value of zinc-doped bioactive glass powders decreases with the increase of zinc content. The zinc-doped bioactive glass powders all have good antibacterial properties.

[0035] Figure 2 A is the gelation time of the hydrogel with different 30Zn58S addition amounts, B is the pH change of the MES buffer after adding different amounts of 30Zn58S, and C is the device for using 1% ZnBG / OSA. The oxidized sodium alginate solution mixed with 1% ZnBG and the adipic acid dihydrazide modified γ-polyglutamic acid solution are placed in two tubes respectively. When extruded, they can be quickly gelled if mixed evenly, and have good injectability. It can be seen from the figure that the gelation time of the composite hydrogel increases with the increase of 30Zn58S content, and the gelation time of 1% ZnBG / OSA is about 15 seconds, which has good injectability.

[0036] Figure 3 A is the bonding strength of hydrogels with different 30Zn58S addition amounts to pig skin; B is the ability of 1% ZnBG / OSA hydrogel to firmly bond to pig skin; C is the bursting pressure of 1% ZnBG / OSA on pig small intestine; D is a diagram of the bursting pressure test device. It can be seen from the figure that 1% ZnBG / OSA hydrogel has good tissue bonding strength.

[0037] Figure 4A in the middle is the coagulation time test. B is a photo of the coagulation time test; from the figure, it can be seen that through the coagulation time test, it can be seen that the 1% ZnBG / OSA hydrogel is less than 150 seconds, which has a good hemostatic effect;

[0038] Figure 5 The results of the antibacterial experiment show that 1% ZnBG / OSA hydrogel has good antibacterial properties.

[0039] Figure 6 1% ZnBG / OSA composite hydrogel ion release rate. From the figure, we can see that 1% ZnBG / OSA composite hydrogel can continuously release calcium, silicon and zinc ions.

Claims

1. A zinc-doped bioactive glass composite hydrogel, characterized in that: include: A polymer containing an aldehyde group, a polymer containing a hydrazide and a buffer solution form a hydrogel as a matrix, and zinc-doped bioactive glass powder is dispersed in the matrix; preferably, the content of the zinc-doped bioactive glass powder is 0.5-2.0wt%.

2. The zinc-doped bioactive glass composite hydrogel according to claim 1, characterized in that: The particle size of the zinc-doped bioactive glass powder is less than 100 microns; The mass ratio of the polymer containing aldehyde groups, the polymer containing hydrazide and the zinc-doped bioactive glass is (1% to 20%): (1% to 20%): (0.5 to 2.0%).

3. The zinc-doped bioactive glass composite hydrogel according to claim 1 or 2, characterized in that: The components of the zinc-doped bioactive glass powder contain inorganic oxides of ZnO, CaO, SiO2 and P2O5; preferably, the components of the zinc-doped bioactive glass powder, based on 100wt% by mass, have a Zn content of 10% to 30%, a P2O5 content of 3 to 20%, a SiO2 content of 40 to 80%, and a CaO content of 10% to 60%.

4. The zinc-doped bioactive glass composite hydrogel according to claim 3, characterized in that: The zinc-doped bioactive glass is doped with at least one of potassium, lithium, magnesium, boron, copper and strontium; the doping content is 1-20%.

5. The zinc-doped bioactive glass composite hydrogel according to any one of claims 1 to 4, characterized in that: The buffer solution comprises at least one of a disodium hydrogen phosphate-sodium dihydrogen phosphate buffer solution, a morpholineethanesulfonic acid buffer solution, a disodium hydrogen phosphate-citric acid buffer solution and a citric acid-sodium citrate buffer solution, and the pH value is 5 to 7; The sum of the mass of the polymer containing aldehyde groups and the polymer containing hydrazide is 1-20wt% of the total mass of the polymer containing aldehyde groups, the polymer containing hydrazide and the buffer solution.

6. The zinc-doped bioactive glass composite hydrogel according to any one of claims 1 to 5, characterized in that: The mass ratio of the aldehyde-containing polymer to the zinc-doped bioactive glass powder is (1-20): (0.5-2.0); The polymer containing aldehyde groups includes sodium alginate oxidized by periodic acid, dextran oxidized by periodic acid, hyaluronic acid oxidized by periodic acid, and aldehyde-modified polyglutamic acid.

7. The zinc-doped bioactive glass composite hydrogel according to any one of claims 1 to 6, characterized in that: The mass ratio of the hydrazide-containing polymer to the zinc-doped bioactive glass powder is (1-20): (0.5-2.0); The hydrazide-containing polymer includes adipic acid dihydrazide-modified polyglutamic acid.

8. A method for preparing the zinc-doped bioactive glass composite hydrogel according to claim 7, characterized in that: include: The buffer solution of the polymer containing aldehyde groups and the buffer solution of the polymer containing amino groups are mixed, and then zinc-doped bioactive glass powder is added to mix into a gel to obtain the zinc-doped bioactive glass composite hydrogel.

9. Use of the zinc-doped bioactive glass composite hydrogel according to claim 1 in preparing wound repair materials.